glp-1 news september 2025 fda warning letters Patients taking an experimental oral drug lost significant Obesity Weekly News - September

The SURPASS and SURMOUNT trials have led the ADA to consider tirzepatide, along with semaglutide, to be very highly efficacious for weight loss [38]

As we navigate the realm of medical advancements, the role of glutathione emerges as a potential ally in our journey towards digestive well-being

This article outlines 7 health benefits of selenium, all backed by science

What to do about it Protein intake and resistance training influence how much lost weight comes from fat versus lean tissue, especially in lower-BMI users

This blend allows researchers to track steady-state data across multiple regulatory mechanisms simultaneously without requiring multi-vial cross-contamination risks